Monte Rosa Therapeutics banks 96 million US dollars The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful…martin09.28.2020
Roche launches new coronavirus antibody test Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development…martin09.18.2020
Investors see great potential in Polyneuron The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million…martin09.17.2020
Lonza set to manufacture coronavirus drug for Humanigen The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza…martin09.15.2020
Roche testing for coronavirus and flu simultaneously The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that…martin09.04.2020
Hengrui Medicine sets up clinical research and development in Basel The Chinese life sciences company Hengrui Medicine is establishing a Swiss subsidiary in Basel. The European hub for clinical research…martin09.02.2020
Polyphor awarded exclusive licensing agreement for China The Basel Area-based company Polyphor has signed an exclusive licensing agreement with Fosun Pharma in China. Fosun Pharma will lead…martin08.31.2020
New label guarantees that data remains in Switzerland With the new “swiss hosting” label, the Basel-based company swiss made software Gmbh is guaranteeing that data will not be…martin08.28.2020
Switzerland ranked in second place globally The chemical and pharmaceutical industry of Switzerland has been ranked number two in the world after the USA in terms…martin08.24.2020
Switzerland Innovation Park Basel Area opens site on Novartis Campus Switzerland Innovation Park Basel Area has opened a new location at the Novartis Campus. From here, the innovation park’s operator,…martin08.17.2020